- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
COSCIENS Biopharma Inc (CSCI)
COSCIENS Biopharma Inc stock price live, this page displays TSX CSCI stock exchange data. View the CSCI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the COSCIENS Biopharma Inc real time stock price chart below.
What Is the COSCIENS Biopharma Inc Stock Price Today?
The COSCIENS Biopharma Inc stock price today is 4.670.
What Is the Stock Symbol for COSCIENS Biopharma Inc?
The stock symbol for COSCIENS Biopharma Inc is "CSCI."
What Stock Exchange Does COSCIENS Biopharma Inc Trade On?
COSCIENS Biopharma Inc is listed and trades on the Toronto stock exchange.
Is COSCIENS Biopharma Inc a Good Stock to Buy?
Determining whether COSCIENS Biopharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CSCI quote. (ISIN: CA22112H1010)
What Is the COSCIENS Biopharma Inc Stock Price Today?
The COSCIENS Biopharma Inc stock price today is 4.670.
What Is the Stock Symbol for COSCIENS Biopharma Inc?
The stock symbol for COSCIENS Biopharma Inc is "CSCI."
What Stock Exchange Does COSCIENS Biopharma Inc Trade On?
COSCIENS Biopharma Inc is listed and trades on the Toronto stock exchange.
Is COSCIENS Biopharma Inc a Good Stock to Buy?
Determining whether COSCIENS Biopharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CSCI quote. (ISIN: CA22112H1010)
4.670
-0.150(-3.11%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.490
4.820
52 wk Range
2.900
10.240
CSCI Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.4904.820
52 wk Range
2.90010.240
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
CSCI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
- COSCIENS Biopharma names new CEO Anna Biehn
- Investing.com
- COSCIENS Biopharma names Anna Biehn as new CEO
- Investing.com
- COSCIENS Biopharma reports key corporate updates
- Investing.com
- COSCIENS Biopharma reports key corporate updates
- Investing.com
COSCIENS Biopharma Inc Company Profile
COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, Colombia, the United Kingdom, and internationally. It operates through Active Ingredient and Pharmaceutical segments. The company offers active ingredients comprising oat beta glucan, a chewable for cholesterol reduction; beta glucan from yeast, a nutraceutical-capsule used as an immune booster; and avenanthramides, a nutraceutical-chewable formulation used to reduce inflammation for the healthcare and cosmetic industries. It also provides Macrilen/Ghryvelin (macimorelin), an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of patients with adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as for endocrinology and oncology indications. The company sells its products through its distribution network. It has license agreements with Pharmanovia, MegaPharm Ltd., ER Kim Pharmaceuticals Bulgaria Eood, and NK MEDITECH Ltd, as well as Agriculture Canada and University of Alberta. The company was formerly known as Aeterna Zentaris Inc. and changed its name to COSCIENS Biopharma Inc. in August 2024. COSCIENS Biopharma Inc. was incorporated in 1990 and is based in Toronto, Canada.
Compare CSCI to Peers and Sector
Metrics to compare | CSCI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCSCIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.6x | −3.5x | −0.5x | |
PEG Ratio | 0.00 | 0.11 | 0.00 | |
Price/Book | 1.1x | 2.5x | 2.6x | |
Price / LTM Sales | 1.2x | 4.2x | 3.0x | |
Upside (Analyst Target) | - | 256.4% | 52.6% | |
Fair Value Upside | Unlock | 14.3% | 8.8% | Unlock |
Earnings
Latest Release
Apr 09, 2025
EPS / Forecast
-2.14 / -3.48
Revenue / Forecast
3.32M / 1.10M
FAQ
What Is the COSCIENS Biopharma (CSCI) Stock Price Today?
The COSCIENS Biopharma stock price today is 4.67
What Stock Exchange Does COSCIENS Biopharma Trade On?
COSCIENS Biopharma is listed and trades on the Toronto Stock Exchange stock exchange.
What Is the Stock Symbol for COSCIENS Biopharma?
The stock symbol for COSCIENS Biopharma is "CSCI."
What Is the COSCIENS Biopharma Market Cap?
As of today, COSCIENS Biopharma market cap is 14.70M.
What Is COSCIENS Biopharma's Earnings Per Share (TTM)?
The COSCIENS Biopharma EPS (TTM) is -6.04.
From a Technical Analysis Perspective, Is CSCI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has COSCIENS Biopharma Stock Split?
COSCIENS Biopharma has split 5 times.
How Many Employees Does COSCIENS Biopharma Have?
COSCIENS Biopharma has 40 employees.
What is the current trading status of COSCIENS Biopharma (CSCI)?
As of 21 Jun 2025, COSCIENS Biopharma (CSCI) is trading at a price of 4.67, with a previous close of 4.82. The stock has fluctuated within a day range of 4.49 to 4.82, while its 52-week range spans from 2.90 to 10.24.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.